ACTRN12615000566538RecruitingPhase 2
Studying the antidepressant effects of intravenous ketamine in patients with major depressive disorder
ational University of Singapore0 sites30 target enrollmentStarted: June 2, 2015Last updated:
Conditions
Trial Snapshot
- Phase
- Phase 2
- Status
- Recruiting
- Sponsor
- Enrollment
- 30
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
- Allocation
- Randomised controlled trial
- Primary Purpose
- Treatment
Eligibility Criteria
- Ages
- 21 Years to 65 Years (—)
- Sex
- All
Inclusion Criteria
- •Major depressive episode according to DSM-IV-TR Disorders
- •- Montgomery-Asberg Depression Rating Scale score of at least 20
- •- On stable doses of oral antidepressant medication
- •- Ability to provide informed consent
Exclusion Criteria
- •- Any unstable medical condition or clinically relevant abnormality that is likely to compromise study conduct, evaluation or safety
- •- Schizophrenia and other psychotic disorders, bipolar disorder, obsessive-compulsive disorder, eating disorder, substance-related disorders
- •- Drug allergy to ketamine or scopolamine
- •- Use of adjunct medications for depression and TCAs
- •- Pregnant or breast-feeding women
- •- Inability to follow procedures in the study protocol for any reason
Investigators
Similar Trials
Not yet recruiting
Not Applicable
Clinical evaluation of the antidepressant effect of the use of probiotics in bipolar disorderRBR-5dhhhddniversidade de São Paulo
Completed
Phase 2
?The effect of depressor septi nasi cutting in nasolabial angle and nasal tip formTip rhinoplasty.Other plastic surgery for unacceptable cosmetic appearanceIRCT201106086745N1Investigator80
Completed
Phase 2
Comparison of Venlafaxine and Sertraline Therapeutic Effects on Depression in Patients with EpilepsyIRCT20210608051515N2Tehran University of Medical Sciences30
Recruiting
Unknown
Acute antidepressant effects and response predictors of wake therapyJPRN-jRCT1030220427Yoshiike Takuya60
Completed
Not Applicable
Exploratory trial of antidepressant therapy for dizzinessSigns and Symptoms: DizzinessSigns and SymptomsDizzinessISRCTN80847419Record Provided by the NHSTCT Register - 2005 Update - Department of Health (UK)64